BCM
PASG icon

Bridgeway Capital Management’s Passage Bio PASG Stock Holding History

Bridgeway Capital Management’s Portfolio PASG Stock Details PASG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-20,803
Closed -$167K – 1266
2025
Q3 		$167K Buy
20,803
+1
+0% +$7 ﹤0.01% 1043
2025
Q2 		$167K Sell
20,802
-4,505
-18% -$32.9K ﹤0.01% 995
2025
Q1 		$179K Sell
25,307
-2,500
-9% -$27K ﹤0.01% 947
2024
Q4 		$315K Hold
27,807
– – 0.01% 910
2024
Q3 		$389K Hold
27,807
– – 0.01% 919
2024
Q2 		$442K Hold
27,807
– – 0.01% 886
2024
Q1 		$751K Buy
27,807
+2,477
+10% +$59.6K 0.02% 820
2023
Q4 		$512K Hold
25,330
– – 0.01% 939
2023
Q3 		$333K Buy
25,330
+5,850
+30% +$96.1K 0.01% 992
2023
Q2 		$367K Hold
19,480
– – 0.01% 995
2023
Q1 		$373K Sell
19,480
-5,000
-20% -$136K 0.01% 953
2022
Q4 		$676K Buy
24,480
+16,325
+200% +$412K 0.02% 823
2022
Q3 		$204K Buy
+8,155
New +$321K 0.01% 1141

Other funds holding PASG

LCM
Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EP
Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $10.8B AUM 38.54% 1-Year Est. Return
YCM
Yiheng Capital Management San Francisco, California $231M AUM 29.07% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Bridgeway Capital Management's PASG Position: Q4 2025 in Review

Bridgeway Capital Management sold out of Passage Bio (PASG) in Q4 2025, closing a stake of 20,803 shares — an estimated $167K sold.

Bridgeway Capital Management first reported a position in PASG in Q3 2022 and held it in 13 quarters. The position peaked at $751K in Q1 2024. 30 funds tracked by Wall St. Rank hold PASG as of Q4 2025.

  • Bridgeway Capital Management reported no remaining Passage Bio position as of Q4 2025 after selling out during the quarter.
  • Bridgeway Capital Management sold 20,803 Passage Bio shares in Q4 2025, an estimated $167K.
  • Bridgeway Capital Management first reported a position in Passage Bio in Q3 2022 and held it in 13 quarters.
  • Bridgeway Capital Management's Passage Bio position peaked at $751K in Q1 2024.
  • 30 funds tracked by Wall St. Rank held Passage Bio as of Q4 2025.

Based on Bridgeway Capital Management's 13F filing for Q4 2025, filed 17 Feb 2026.